中国医学前沿杂志（电子版）Issue(6)：133-135,3.
胸腺五肽治疗伴并发症肺结核效果观察
The efifcacy of thymopentin on tuberculosis with complications
刘士甫 1张鑫 1赵磊 1康书慧 1曹金凤 1高伟1
作者信息
- 1. 石家庄市第五医院 结核科，石家庄056000
- 折叠
摘要
Abstract
ObjectiveTo explore the efifcacy of thymopentin on tuberculosis with complications.Method 120 patients with consecutive tuberculosis were enrolled from March 2013 to January 2014 in our hospital, 60 cases were randomly assigned to research group and 60 cases to control group. Research group patients were treated with thymopentin+basis of anti-tuberculosis treatment, control group patients were treated with basis of anti-tuberculosis treatment. Clinical efifcacy and safety between the two groups were observed after 1, 2 and 3 months respectively.ResultThe total effective rate was 48.3%, 61.7%, 73.3% in control group at 1, 2 and 3 months, while which in research group was 60.0%, 75.0% 83.3%; respectively, there was signiifcant differences between the two groups (P<0.05). The adverse reaction rate was 48.3%, 71.7%, 60.0% in control group at 1, 2 and 3 months, while which in research group was 21.7%, 23.3%, 13.3% respectively, there was signiifcant differences between the two groups (P<0.05).ConclusionThymopentin can obviously improve the clinical curative effect on tuberculosis with complications and reduce the occurrence of adverse reactions, which is safety and worth of popularizing.关键词
胸腺五肽/并发症/肺结核/临床疗效Key words
Thymopentin/Complications/Tuberculosis/Clinical curative effect引用本文复制引用
刘士甫,张鑫,赵磊,康书慧,曹金凤,高伟..胸腺五肽治疗伴并发症肺结核效果观察[J].中国医学前沿杂志（电子版）,2015,(6):133-135,3.
